论文部分内容阅读
目的探讨胺腆酮治疗急性心肌梗死并发房颤的临床疗效。方法选取2013年7月至2015年7月我院收治的急性心肌梗死并发房颤的58例患者资料,按治疗方法的不同分为观察组与对照组,每组29例,观察组为给予胺碘酮治疗的患者,对照组为给予盐酸普罗帕注射液治疗的患者,对比两组患者的房颤控制率、转复率及不良反应情情况。结果 24h内观察组患者的的房颤控制率、转复率均高于对照组,差异有统计学意义(P<0.05)。不良反应发生率差异无统计学意义(P>0.05)。结论胺碘酮治疗急性心肌梗死并发房颤的临床治疗效果显著,可缩短房颤时间,可明显改善患者的心功能状态,提高患者治疗后的生存质量,值得在临床中推广应用。
Objective To investigate the clinical efficacy of amylose in the treatment of acute myocardial infarction complicated with atrial fibrillation. Methods Fifty-eight patients with acute myocardial infarction complicated with atrial fibrillation admitted to our hospital from July 2013 to July 2015 were divided into observation group and control group according to the different treatment methods, with 29 cases in each group. The observation group was given amine Patients in the control group were treated with propofol hydrochloride. The control rate, recovery rate and adverse reactions of atrial fibrillation were compared between the two groups. Results The control rate and recovery rate of atrial fibrillation in the observation group within 24 hours were higher than those in the control group (P <0.05). There was no significant difference in the incidence of adverse reactions (P> 0.05). Conclusion Amiodarone is effective in the treatment of acute myocardial infarction complicated with atrial fibrillation. It can shorten the time of atrial fibrillation, improve the cardiac function and improve the quality of life of the patients after treatment. It is worth popularizing in clinic.